Phase 1/2

SOUTH SAN FRANCISCO, Calif., June 26, 2026 Star Therapeutics announced it will present complete safety and efficacy data from...

DALLAS, June 25, 2026 Taysha Gene Therapies announced multiple presentations highlighting the clinical progress of its investigational TSHA-102 gene...

LONDON — November 26, 2025. Tangram Therapeutics has submitted a Clinical Trial Application (CTA) to the UK Medicines and...